Efficacy of combination therapy with pembrolizumab and axitinib for metastatic renal collecting duct cell carcinoma: A report on two cases.
Shinji TamadaDaiki IkarashiTakashi TsuyukuboKazuhiro IwasakiKazumasa IsurugiSadahide OnoRyo TakataHiromitsu FujisawaWataru ObaraPublished in: IJU case reports (2022)
Combined immunotherapy with pembrolizumab and axitinib may be effective for metastatic renal collecting duct carcinoma.